MARTIN CAMACHO: Open Payments
NPI 1275613424 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $587 · 2025 $846
Food & beverage: $747Education: $99
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 7 | $304 |
| ABIOMED | 5 | $119 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| LeMaitre Vascular, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Baylis Medical Technologies Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $23 |
Products named: OPSUMIT, UPTRAVI, FARXIGA, ARTEGRAFT VASCULAR GRAFT, CAMZYOS, ELIQUIS, WAINUA, Kerendia.
Industry payments across MT — which companies pay providers there.
